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Abstract Gold nanoparticles (GNPs) are emerging as a novel tool to improve existing cancer therapeutics. GNPs are
being used as radiation dose enhancers in radiation therapy as well as anticancer drugs carriers in chemotherapy. However,
the success of GNP-based therapeutics depends on their ability to penetrate tumor tissue. GNPs of 20 and 50 nm diameters
were used to elucidate the effects of size on the GNP interaction with tumor cells at monolayer and multilayer level. At
monolayer cell level, smaller NPs had a lower uptake compared to larger NPs at monolayer cell level. However, the order was
reversed at tissue-like multilayer level. The smaller NPs penetrated better compared to larger NPs in tissue-like materials.
Based on our study using tissue-like materials, we can predict that the smaller NPs are better for future therapeutics due to
their greater penetration in tumor tissue once leaving the leaky blood vessels. In this study, tissue-like multilayer cellular
structures (MLCs) were grown to model the post-vascular tumor environment. The MLCs exhibited a much more extensive
extracellular matrix than monolayer cell cultures. The MLC model can be used to optimize the nano–micro interface at tissue
level before moving into animal models. This would accelerate the use of NPs in future cancer therapeutics.
Keywords Gold nanoparticles  Multilayer cellular structures  Tissue penetration  Hyper spectral imaging  Size
dependence
1 Introduction
Gold nanoparticles (GNPs) and other NPs have emerged as
one of the most robust and flexible tools in cancer research.
Their applications cover the full breadth of the clinical
spectrum from enhancing diagnostic imaging to pho-
tothermal and photodynamic therapy, drug delivery, and
radiosensitization [1, 2]. NPs were found to enter cells
mostly via receptor-mediated endocytosis (RME) [3]. At
the monolayer level, GNP uptake is size dependent [4]. For
example, smaller NPs have a lower uptake compared to
larger NPs as illustrated in Fig. 1. However, most of the
outcomes related to NP uptake and transport derived from
monolayer cell cultures ultimately fall short of agreeing
with the outcomes derived from an in vivo tumor envi-
ronment. Hence, the success of several NP-based therapies
and systems is sometimes overstated and in vivo trials fall
short of expectations [5, 6]. In this study, a new multilayer
cell culture is used in an attempt to bridge the gap between
the in vitro and in vivo studies.
In post-vascular tumor tissue, the local environment is
much more complex than in monolayer cell cultures due to
the presence of the extracellular matrix (ECM). The ECM
is a structural and biological support network that arises
from proteins and molecules secreted by cells as they grow.
The composition and architecture of the ECM vary from
one cell line to another since different cells secrete different
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proteins with different functions. The ECM carries out a
number of important functions, enables cell-to-cell com-
munication and cell adhesion, and provides a rigid support
structure that gives tissues its shape. This support structure
also determines the permeability of tissue to molecules and
other particles and sometimes acts as a barrier for transport,
as discussed in the next section [7–10]. Eosin is a florescent
dye used for staining proteins in the cytoplasm of the cells
and collagen in the ECM. As illustrated in Fig. 1, ECM
(marked in green) is not heavily present in between cells
compared to tissues. Hence, ECM does not act as a barrier
for NP transport in monolayer cell cultures whereas it does
for NP transport in tissue-like MLC structures. For exam-
ple, it was shown that NP penetration into the core tumor
spheroids diminished as particle sizes increased from 20 to
100 nm NPs [9]. Several factors have been proposed to
explain the poor penetration and distribution of GNPs in
solid tumors. These factors include the binding of GNPs to
tumor tissue, increased interstitial fluid pressure, and hin-
dered diffusion due to cell packing and the ECM [7, 8, 11–
13]. Furthermore, the elimination of the pressure gradient in
solid tumors yielded only minimal gains in macromolecule
delivery which suggests that cell packing and ECM are
major factors in the differences between monolayer and
solid tumor penetration dynamics [8, 12, 14].
The geometry of the MLCs also sets it apart from other
3D cell cultures, such as the multicellular spheroid, as dis-
cussed in the previous section. In the spheroid geometry,
drugs and agents pass radially inwards from the edges of the
spheroid. This geometry is often the reverse of in vivo
physiology and makes it difficult to ascertain the penetration
of drugs in a solid tumor. The MLC provides a top-down or
side-to-side geometry and better mimics the distribution of
agents out of a blood vessel and down into tissue [15–17]. In
addition, it has been reported that within tumors, cells can
appear further than 150 lm from the nearest blood vessel
[18]. In such a case, any agents delivered to the tumor
through the bloodstream will have to navigate in the
heterogeneous tumor environment without assistance from
any vascular network to reach their target cells. Our pro-
posed MLC model can also be used to examine the pene-
tration and transport of GNPs through such tissue.
While in vivo tumors offer the most clinically relevant
tool for determining the spatial distribution and penetration
of GNPs, the complex biological factors prevent a focused
analysis of the individual components that contribute to the
transport of GNPs and other agents [19–21]. Using this
MLC model, the limiting effects of the ECM, the thickness
of cell layers, and the GNP transport mechanisms of GNPs
in tumor tissue can be measured in a less complex biological
microenvironment. In this study, we investigated the size
dependency of NP transport in tumor tissues using the MLC
model for the first time. We were able to image the pene-
tration of NPs in these tissue sections for the first time. The
accumulation of GNPs in the MLC tissue was measured to
determine the major factors affecting GNP transport
through tumor tissue in the absence of vasculature. Hence,
the MLC model can be used to improve the design of NP-
based systems for improved outcomes in imaging and
therapeutic applications in the field of nanomedicine.
2 Materials and Methods
2.1 Selection of Cell Lines
In this study, two cell lines, MDA-MB-231 and MCF-7,
were chosen as a model tumor type. Both cell lines are




Fig. 1 Schematic explaining the size dependency of NP transport in monolayer versus multilayer. a Cellular uptake of smaller NPs is lower at
monolayer level. b Larger GNPs have greater cell uptake than smaller GNPs at the monolayer level. c Smaller GNPs have better penetration in
the multilayer tissue than larger GNPs. d Larger GNPs exhibit limited penetration through ECM
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invasive ductal carcinomas and thus represent one of the
most commonly encountered types of cancers. This also
means that both cell lines are derived from the same tissue
which helps limit the potential variations between tissue
types. In addition, both cell lines have comparable dou-
bling times and sizes. However, the MDA-MB-231 cell
line has been identified as being far more aggressive and
invasive than the MCF-7 cell line [22–28]. This key dif-
ference affects the makeup and proliferation of not only the
cells themselves but also the ECM that surrounds them.
2.2 Synthesis of GNPs
The GNPs were synthesized via the reduction of HAuCl4
by sodium citrate, which is more commonly referred to as
the Turkevitch’s method [29]. By varying the amount of
sodium citrate, this method can yield NPs of varying sizes.
In summary, 300 lL of 1 % gold salt was added to 30 mL
of doubled distilled water and brought to boil while stir-
ring. The amount of reducing agent (1 % sodium citrate)
added was 400 and 100 lL to produce 20 and 50 nm,
respectively. The GNPs were characterized by transmission
electron microscopy (TEM, H7000, Hitachi Corp. Tokyo,
Japan), UV-spectroscopy (Lambda 40; PerkinElmer, Wal-
tham, MA), and dynamic light scattering (DLS) using 90
Plus Particle Sizer Analyzer (Brookhaven Instruments
Corp. New York, NY) to determine the size of the particles.
The UV–visible peak wavelengths for 20 and 50 nm GNPs
were 520 and 525 nm, respectively. According to TEM, the
diameters of the NPs were 19.5 (±3.3) and 52.4 (±5.2).
According to DLS measurements, the hydrodynamic
diameters of the NPs were 24.2 (±0.6) and (52.6 ± 0.8).
This information is given under supplementary information
as well.
2.3 The CytoViva Imaging Technology
The CytoViva technology used in this study was specifi-
cally designed for optical observation and spectral confir-
mation of NPs as they interact with cells and tissues. The
illumination of the microscope system utilizes oblique
angle illumination to create high-resolution dark-field
images. Figure 2a, d shows dark-field hyperspectral images
of GNPs of sizes 20 and 50 nm. The GNPs appear bright
owing to their high scattering cross section. Hyperspectral
imaging (HSI) was used in conjunction with the dark-field
microscope to obtain reflectance spectra from each pixel in
the dark-field image. Spectral angle mapping can be per-
formed to conduct a pixel-by-pixel matching of any spectra
obtained by the system. This procedure was used to create
a map of GNPs based on their reflectance spectra within the
sample. The hyperspectral image shows which HSI pixels
matched the reference GNP spectrum within a given
spectral angle threshold set at 0.15 radians for this study.
Figure 2b, e shows the hyperspectral images with an
overlaid spectral angle map where the red dots represent
matching GNP reference spectra. The reference spectrum
was chosen from a sample of GNP spectra collected via the
HSI image. It is representative of a typical GNP spectrum
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Fig. 2 Characterization of GNPs. a, b, c The dark-field hyperspectral image, mapped image using the reference spectra marked in red in (c), and
reflectance spectra of GNPs of size 20 nm, respectively. d, e, f The dark-field hyperspectral image, mapped image using the reference spectra
marked in red in (f), and reflectance spectra of GNPs of size 50 nm, respectively. (Color figure online)
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information for a few GNPs in the Fig. 2a, d. The reference
spectrum marked in red in Fig. 2c, f was used to map the
GNP distribution in Fig. 2b, e. This HIS imaging of GNPs
in cells and tissues has been very practical since it is not
necessary to optically label NPs. Furthermore, it is also
possible to extract spectral info from each pixel to verify
whether the bright spots appears in the sample image are
actually GNPs. This imaging technique requires less
preparation in comparison to TEM and is also cost
effective.
2.4 Growth of MCL Structures
To better model the tumor environment, cells were cultured
on a semi-permeable membrane, as described by Minch-
inton et al. [17]. The multi-layered cell culture develops
into a thick mat of cells that acts as a barrier to the pene-
tration of drugs and GNPs much in the same way as solid
tumors and multicellular spheroids. They have been used to
study the penetration of a variety of anticancer drugs as
well as agents specifically targeted to hypoxic and nutrient
deprived cells, where penetration is of the utmost impor-
tance [16]. Previous work using MLCs demonstrated the
development of hypoxia and necrosis in MLCs greater than
150-lm thick. The appearance of necrosis and hypoxia at
150 lm of tissue thickness presents an upward bound on
the tissue sizes considered in this study [15, 18, 30–33].
The effects of hypoxia and necrosis on the transport of
GNPs were shown recently to be quite complex and will be
pursued at the multilayer level in future studies [34].
The growth of the MCLs began with the growth of
monolayer cells in a 5 % CO2 environment at 37 C. After
reaching confluence, these cells were trypsinized, cen-
trifuged, suspended in media, and counted. Approximately
150,000–200,000 cells were seeded onto a microporous
membrane insert (Millicell, Bedford, MA) (see Fig. 3a).
After allowing the cells to attach for two to four hours, the
inserts were washed with PBS to remove unattached cells
and then suspended in stirred media to grow (see Fig. 3b).
With pore sizes of 3 lm, the inserts allowed for the passage
of stirred media through the base of the insert as seen in
Fig. 3c. A TEM image of a tissue cross section is shown in
Fig. 3c.
Two breast cancer cell lines were used in this study:
MCF-7 and MDA-MB-231. Cells were grown on the MLC
insert in Dulbecco0s Modified Eagle0s Medium (LifeTech-
nologies Inc. Burlington, ON) with 10 % Fetal Bovine
Serum (Sigma-Aldrich, Oakville, ON). Figure 3d shows an
image of an unstained tissue cross section of MCF-7 cells.
The ECM and cytoplasm of the cells within the tissue were
stained with eosin for visualization (Fig. 3e). The darker
areas in the image are the nuclei of cells. The nucleus will
not be stained with eosin. The thickness of the tissue was
controlled by the growth period. MLC incubation with NPs
was conducted by hanging the MLCs in multiwall plates
followed by filling the top of the inserts with the GNP and
media mixture. A supply of fresh media was placed below
the MLC to allow for GNPs that had penetrated the entire
MLC structure to diffuse through. MLCs were examined
and their thicknesses were measured. The thickness of an
MLC was found by taking the average thickness over at
least 10 slices.
2.5 Qualitative Analysis
To qualitatively measure the distribution of the GNPs as
well as to provide a measure of MLC growth characteris-
tics, MLC inserts were frozen in optimum cutting tem-
perature (OCT) compound for sectioning. The frozen
MLCs were then sectioned (Cryostat CM1900; Leica,
Wetzlar, Germany) into 10–20-lm-thick sections and
placed onto slides for imaging. Tissue sections were
stained with eosin to show the presence of ECM (Au-
tostainer XL; Leica, Wetzlar, Germany). Stained tissue
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Fig. 3 Growth of MCL structures. a General principles of MCL
growth involve seeding monolayer cells onto a semi-permeable
membrane for growth. b The basic MCL growth setup showing the
insert suspended in stirred media. c TEM image of the MCL tissue. d,
e Unstained and stained images of MCL tissue cross sections,
respectively
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sections were imaged using the CytoViva HSI dark-field
microscope. By examining the images acquired by HSI, a
qualitative examination of the layer-by-layer penetration
was deduced.
3 Results and Discussion
3.1 Size Dependence of Gold Nanoparticle Uptake
at Monolayer Level
Of particular interest to NP research is the size depen-
dence of NP uptake, which has been confirmed by a
number of independent groups [4, 35, 36]. It was found
that the uptake of GNPs across a variety of cell lines was
highest for 50 nm GNPs, and that smaller (\40 nm) as
well as larger ([80 nm) GNPs had almost a two-fold
decrease in uptake per cell [4]. We used 20 and 50 nm
GNPs for our monolayer and multilayer study. At the
monolayer level, our quantitative and qualitative results
showed that 20 nm NPs have a lower uptake compared to
50 nm NPs as illustrated in Fig. 4. This is in agreement
with the previous studies. This size dependence is
explained by the energy dynamics surrounding RME with
50-nm spheres showing a significantly higher uptake than
smaller sizes [37, 38]. As particles interact with the sur-
face of the cell, receptors are recruited and bound to the
GNP in an exothermic process. This binding of receptors
to the surface of the particle provides the cell with the
energy required to begin the invagination process that will
surround the particle and prepare it for entry into the cell.
Smaller particles provide less surface area for receptors to
bind, and as a result offer less total energy for the
invagination process lowering their uptake. The reflec-
tance spectra from GNPs localized within cells did not
show any clear difference for cells incubated with 20 and
50 nm GNPs (see Fig. 4f, g). This could be due to the
fact that NPs are in vesicles together following internal-
ization. Hence, it is hard to differentiate reflectance
spectra from individual NPs.
3.2 Size Dependence of Gold Nanoparticle
Transport at Multilayer Level Using MLC
Model
As discussed in the previous section, 50 nm GNPs are





















































Fig. 4 Monolayer uptake of GNPs. a The hyperspectral image of cells internalized with 20 nm sized GNPs. Bright dots represent GNP clusters
localized within cells. b GNP clusters within the cells were mapped using one of the reflectance spectra of GNPs. c The hyperspectral image of
cells internalized with 50 nm sized GNPs. Bright dots represent GNP clusters localized within cells. d GNP clusters within cells were mapped
using the reflectance spectrum of GNPs. e The GNP uptake per cell for 20 and 50 nm GNPs across both cell lines. f, g The reflectance spectra for
the 20 and 50 nm GNPs in the monolayer cell samples are shown in (a, c)
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at monolayer level. However, it was unknown as to whe-
ther or not this effect would carry over into the tissue-like
multilayer model due to the presence of ECM. To test this,
50-nm GNPs were incubated at the same concentration and
for the same time period, in MLCs as the 20 nm GNPs. The
results of these experiments are shown in Fig. 5. Transport
of smaller NPs through MCF-7 and MDA-MB-231 is
shown quantitatively and qualitatively in Fig. 5a–c. Smal-
ler NPs seem to have a higher penetration throughout the
tissue. However, transport of larger NPs through MCF-7
and MDA-MB-231 is lower as shown in Fig. 5d–f. These
results suggest that the optimal particle size dependence of
GNP uptake is reversed in the multilayer model in com-
parison to the monolayer model. Figure 5 shows that the
overall penetration of larger GNPs is lower than in smaller
GNPs. These results further suggest that the ECM plays a
larger role in the transport of GNPs through tissue com-
pared to the individual cells themselves. Penetration of the
GNPs was mapped for each NP size using CytoViva HSI
dark-field microscope as illustrated in Fig. 6. The quali-
tative images show that the penetration of smaller GNPs is
better than in larger GNPs. This seems to suggest that the
diffusive nature of ECM transport is far more pronounced
with the 50 nm GNPs. This also highlights the importance
of the ECM-limiting effect in the much less structured
MDA-MB-231 tissue as opposed to the more ordered and
thus more prohibitive MCF-7 tissue. This result is cor-
roborated by several studies that have proposed the effects
of collagen content and ECM structure as the major fac-
tors in the prohibition of macromolecule penetration
through tumor tissue [13, 19–21]. The reflectance spectra
from GNPs localized in the ECM and cells were plotted
(Fig. 6c, f).
Examination of the rate of change in accumulation as
a function of tissue thickness (Fig. 7a, b) provides a
qualitative look at the penetration of GNPs in the MCL
tissue. The transport of NPs as a function of depth was
also analyzed as illustrated in Fig. 7c, d. The depth
profile used is shown in Fig. 7e. For the 20 nm GNPs, it
appears that the particles were able to penetrate and
accumulate in the deeper tissue. For 50 nm GNPs, the
overall accumulation and penetration is lower for both
cell lines. Furthermore, there is an increase in penetration
of up to approximately 100 lm of thickness. However,
there is then a very rapid falloff in penetrative ability

















































Fig. 5 Penetration of GNPs of different sizes in tissue-like MLC structures. a The quantitative determination of the penetration of GNPs in
MCLs for the 20 size GNPs in MDA-MB-231 and MCF-7 cells. b, c Dark-field images showing penetration of 20 nm GNPs through MDA-MB-
231 and MCF-7 tissues, respectively. d The quantitative determination of the penetration of GNPs in MCLs for the 50 size GNPs in MDA-MB-
231 and MCF-7 cells. e, f Dark-field images showing penetration of 50 nm GNPs through MDA-MB-231 and MCF-7 tissues, respectively
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indicate that 100 lm is the maximum penetrative dis-
tance of 50 nm GNPs in tissue-like materials developed.
The slow diffusion of larger NPs through tumor tissue
could be due to the presence of ECM, as discussed
below.
In epithelial cells, the ECM combines the use of a highly
organized collagen network, hyaluronic acid, and a number
of proteins to prohibit the passage of macromolecules
through tissue. Transport through the ECM is largely
mediated via diffusion, and thus, the ECM is less perme-




In the equation above, D is the diffusion coefficient in
m s-1 (often cm s-1), kb as the Boltzmann consent, T as
the temperature in K, l as the viscosity in kg (s m)-1, and
Rh as the hydrodynamic radius of the passing particle in m.
This relation assumes spherical particles of a homogenous
material with a low Reynolds number and no interaction
between the particles. As such, it is not a perfect repre-
sentation of the present situation but it provides a baseline
model to predict the overall trends in particle penetration as
a function of particle size.
Several studies have noted that the limiting effects of
the ECM are tied to collagen content and the structural
organization of the ECM itself [7, 8]. Although convec-
tion through the interstitial matrix is an important part of
interstitial fluid and particle movement, it is limited by
the hypertension found in the interstitium [11, 22, 39].
Many anticancer agents such as liposomes and gene
vectors are large molecules ranging in size from 90 to
300 nm. Nanoparticle agents being developed also vary
greatly in size ranging from 2 to 200 nm. Thus, diffusion
through the interstitial matrix of the tumor presents a
major barrier to the delivery of therapeutic agents and
drugs.
In addition, cancer cells have been shown to disrupt
and change the composition and makeup of the ECM.
Invasive species in particular have been shown to break
down the collagen that helps provide the ECM with its
ability to limit the flow of foreign particles through tissue
[25, 26]. The two cell lines used in this study are thus
separated by the makeup and composition of their
respective ECM. The measurements taken will establish
what effect the ECM has on the transport of GNPs in
tissue. According to Fig. 7c–d, NP penetration is better in
deeper tissues in MDA-MB-231 in comparison to MCF-7.










































Fig. 6 Spectral mapping of size-dependent NP penetration through tissue. a, b Unmapped and mapped images of 20 nm GNPs penetrated
through tissue, respectively. c The reflectance spectra obtained for the 20 GNPs localized in the tissue. d, e Unmapped and mapped images of
50 nm GNPs penetrated through tissue, respectively. f The reflectance spectra obtained for the 50 GNPs localized in the tissue
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tumor tissues. One other factor to consider when dis-
cussing the penetration dynamics in solid tumors is the
tortuosity of the path taken by particles through tumor
tissue. Particles traversing or penetrating tissue are pre-
sented with cellular obstacles that force the particles on
tortuous paths through the interstitial space [19, 31]. The
tortuosity is not only difficult to measure but also will
vary greatly between cell lines and also within a single
tumor [19].
4 Conclusions
The size dependence of GNP uptake at the monolayer
level appears to be reversed in the multilayer structures.
Figure 8a summarizes the results and compares the uptake
per cell for the monolayer and multilayer study. Fig-
ure 8b, c shows the reflectance spectra for both sizes of
the GNPs across both cell lines. Both sizes of GNPs show
broader peaks in the monolayer cultures. This could be
the result of the clustering of GNPs that occurs upon
entry into the cells where they are packaged into lyso-
somes. This result also suggests that GNPs may be
traversing the ECM one at a time or at least in lower
quantities than they are produced when GNPs are clus-
tered into lysosomes. The results suggest that GNP or NP
systems that aim to improve particle passage through the
ECM might perform better in the in vivo environment. So
far, the design of GNP systems has largely rested on
achieving better GNP–cell interactions and improving the
outcomes of RME. This design philosophy ignores the
effects of the ECM which has been shown here to be
potentially as important a factor in the transport of GNPs
in solid tumors as the cells themselves. Based on
nanoparticle penetration in tissue-like materials, smaller
NPs would be better since it allows deeper tumor pene-
tration. In the future, ligand-bound GNP systems can be
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Fig. 7 Comparison of NP penetration as a function of size of the NPs. a, b GNP penetration as a function of size and tissue thickness in MCF-7
and MDA-MB-231 cells, respectively. c, d Penetration of GNPs as a function of tissue depth for 20 and 50 nm GNPs, respectively. e Schematic
outlining the various ‘depths’ in MLC tissue structures
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actively improve the overall accumulation of GNPs at
depth in solid tumors.
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